Evidence map›Paper›PMID 38190323›Full record

ArticleClinical and experimental immunology2024

Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.

Tamaki Iwai, Ayako Ohyama, Atsumu Osada, Taihei Nishiyama, Masaru Shimizu, Haruka Miki, Hiromitsu Asashima, Yuya Kondo, Hiroto Tsuboi, Seiya Mizuno and 3 more

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Macrophages with ITIH4 overexpression attenuate inflammatory responses and regulate intestinal epithelial cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Tamaki IwaiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Ayako OhyamaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID 0009-0007-9105-5806
Atsumu OsadaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Taihei NishiyamaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Masaru ShimizuDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Haruka MikiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Hiromitsu AsashimaDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Yuya KondoDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID 0000-0002-1708-4402
Hiroto TsuboiDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID 0000-0001-9067-0961
Seiya MizunoTransborder Medical Research Center, University of Tsukuba, Tsukuba, Japan.
Satoru TakahashiTransborder Medical Research Center, University of Tsukuba, Tsukuba, Japan.
Akihito IshigamiMolecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Japan.
Isao MatsumotoDepartment of Rheumatology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID 0000-0002-7995-9294
University of Tsukuba · JPTokyo Metropolitan Institute of Gerontology · JP

Funding

Japan Society for the Promotion of Science
6 · The paper itself

Abstract

Inter-α-trypsin inhibitor heavy chain 4 (ITIH4) is a major protein in serum and reported to be upregulated at the onset of rheumatoid arthritis (RA). Its citrullinated form, cit-ITIH4, is specifically found in the serum and synovial fluid of patients with RA. However, the detailed function of ITIH4 in arthritis remains unknown. The aim of this study was to clarify the role of ITIH4 and cit-ITIH4 using experimental arthritis models. ITIH4 and cit-ITIH4 expression was examined in steady-state mice and two different arthritis models, and their pathological effects were examined in Itih4-deficient mice. In naïve C57BL/6 (WT) mice, ITIH4 was expressed as mRNA in the liver and the lung and was expressed as protein in serum and hepatocytes. In K/BxN serum transferred arthritis (K/BxN-STA) and collagen-induced arthritis (CIA), ITIH4 and cit-ITIH4 in sera were increased before the onset of arthritis, and cit-ITIH4 was further increased at the peak of arthritis. In Itih4-deficient mice, citrullinated proteins in serum and joints, especially 120 kDa protein, were clearly diminished; however, there was no significant difference in arthritis severity between WT and itih-/- mice either in the K/BxN-STA or CIA model. CIA mice also exhibited pulmonary lesions and itih4-/- mice tended to show enhanced inflammatory cell aggregation compared to WT mice. Neutrophils in the lungs of itih4-/- mice were significantly increased compared to WT mice. In summary, ITIH4 itself did not alter the severity of arthritis but may inhibit autoimmune inflammation via suppression of neutrophil recruitment.

Indexed as

Alpha-GlobulinsArthritis, ExperimentalArthritis, RheumatoidAnimalsDisease Models, AnimalHumansMiceMice, Inbred C57BLProteinase Inhibitory Proteins, SecretoryProteinsAlpha-Globulinsinter-alpha-inhibitorItih4 protein, mouseProteinase Inhibitory Proteins, SecretoryProteinsarthritisautoimmunitychemotaxis/migrationlungneutrophils

Identifiers

PMID38190323
PMCPMC10876112
OpenAlexW4390674673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.